Advocacy Actions
Roundtable with MOFCOM Official on European Business Operations in China
Roundtable with MOFCOM Official on European Business Operations in China
Read moreComments to the National Medical Products Administration (NMPA) on Standards for Cosmetics Production Quality, Administrative Measures for Cosmetics Adverse Effect Monitoring, and Management Regulations for Cosmetic Sampling Inspection
On 15th September 2020, the Cosmetics Working Group submitted the comments to NMPA upon Standards for Cosmetics Production Quality, Administrative Measures for Cosmetics Adverse Effect Monitoring, and Management Regulations for Cosmetic Sampling Inspection regarding articles with different opinions from member companies.
Read moreComments to the National Medical Products Administration (NMPA) on Document requirements for Guidelines for the Evaluation of Cosmetic Efficacy Claims
On 17th Sept 2020, the Cosmetics Working Group submitted the comments to NMPA upon the Document requirements for Guidelines for the Evaluation of Cosmetic Efficacy Claims regarding articles with different opinions from member companies.
Read moreComments to the National Medical Products Administration (NMPA) on Document Requirements for Cosmetic Product Registrations and Notifications and Document Requirements for New Ingredient Registrations and Notifications
On 15th September 2020, the Cosmetics Working Group submitted the comments to NMPA upon Document Requirements for Cosmetic Product Registrations and Notifications and Document Requirements for New Ingredient Registrations and Notifications regarding articles with different opinions from member companies.
Read moreComments to the State Administration for Market Regulation (SAMR) on the Guiding Opinions on Strengthening the Supervision of Network Live Marketing Activities (Draft for Comments)
The European Chamber submitted collated comments to the State Administration for Market Regulation (SAMR) on the Guiding Opinions on Strengthening the Supervision of Network Live Marketing Activities (Draft for Comments)
Read moreSubmitted Comments to the National Medical Products Administration (NMPA) on the Product Safety Assessment Guidelines
On 28th August 2020, the Cosmetics Working Group submitted the comments to NMPA upon the Product Safety Assessment Guidelines regarding articles with different opinions from member companies.
Read moreSubmitted Comments to the National Medical Products Administration (NMPA) on Product Classification Scheme
On 28th August 2020, the Cosmetics Working Group submitted the comments to NMPA upon the Product Classification Scheme regarding articles with different opinions from member companies.
Read moreSubmitted Final Comments to the National Medical Products Administration (NMPA) on the Management Rules for Cosmetic Registration
On 19th August 2020, the Cosmetics Working Group submitted the final comments to NMPA Division 1 upon the Management Rules for Cosmetic Registration regarding articles with different opinions from member companies.
Read moreSubmitted Final Comments to the National Medical Products Administration (NMPA) on the Measures on Supervision and Administration of Cosmetic Manufacture and Operation
On 19th August 2020, the Cosmetics Working Group submitted the final comments to NMPA upon the Measures on Supervision and Administration of Cosmetic Manufacture and Operation regarding articles with different opinions from member companies.
Read moreMeeting with EUD DG Grow first counsellor Frank Schmiedel
On 7th August, a meeting with the first counsellor of the Delegation of the European Union Frank Schmiedel.
Read more